Amplification of Inflammation by Lubricin Deficiency Implicated in Incident, Erosive Gout Independent of Hyperuricemia
Arthritis & Rheumatology · 2023-05 · 75 (5) · 794-805
DOI: 10.1002/art.42413 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 10.03.2023. Verfasst von Khaled Elsaid und 21 weiteren Autor:innen. Beteiligte Einrichtung: Chapman University School of Pharmacy, Irvine, California. Hauptthemen laut MEDLINE: Hyperuricemia, Gout, Arthritis, Gouty. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: BLRD VA, NIAMS NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Objective
In gout, hyperuricemia promotes urate crystal deposition, which stimulates the NLRP3 inflammasome and interleukin‐1β (IL‐1β)–mediated arthritis. Incident gout without background hyperuricemia is rarely reported. To identify hyperuricemia‐independent mechanisms driving gout incidence and progression, we characterized erosive urate crystalline inflammatory arthritis in a young female patient with normouricemia diagnosed as having sufficient and weighted classification criteria for gout according to the American College of Rheumatology (ACR)/EULAR gout classification criteria (the proband).
Methods
We conducted whole‐genome sequencing, quantitative proteomics, whole‐blood RNA‐sequencing analysis using serum samples from the proband. We used a mouse model of IL‐1β–induced knee synovitis to characterize proband candidate genes, biomarkers, and pathogenic mechanisms of gout.
Results
Lubricin level was attenuated in human proband serum and associated with elevated acute‐phase reactants and inflammatory whole‐blood transcripts and transcriptional pathways. The proband had predicted damaging gene variants of NLRP3 and of inter‐α trypsin inhibitor heavy chain 3, an inhibitor of lubricin‐degrading cathepsin G. Changes in the proband's serum protein interactome network supported enhanced lubricin degradation, with cathepsin G activity increased relative to its inhibitors, SERPINB6 and thrombospondin 1. Activation of Toll‐like receptor 2 (TLR‐2) suppressed levels of lubricin mRNA and lubricin release in cultured human synovial fibroblasts ( P < 0.01). Lubricin blunted urate crystal precipitation and IL‐1β induction of xanthine oxidase and urate in cultured macrophages ( P < 0.001). In lubricin‐deficient mice, injection of IL‐1β in knees increased xanthine oxidase–positive synovial resident M1 macrophages ( P < 0.05).
Conclusion
Our findings linked normouricemic erosive gout to attenuated lubricin, with impaired control of cathepsin G activity, compounded by deleterious NLRP3 variants. Lubricin suppressed monosodium urate crystallization and blunted IL‐1β–induced increases in xanthine oxidase and urate in macrophages. The collective activities of articular lubricin that could limit incident and erosive gouty arthritis independently of hyperuricemia are subject to disruption by inflammation, activated cathepsin G, and synovial fibroblast TLR‐2 signaling. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Chapman University School of Pharmacy, Irvine, California.
- Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, and Department of Biochemistry, University of Otago, Dunedin, New Zealand.
- Department of Pharmacology, School of Medicine, and Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego, California.
- VA San Diego Healthcare System, San Diego, and Department of Medicine, UC San Diego, La Jolla, California.
- The Ottawa Hospital, Division of Rheumatology, University of Ottawa, Canada.
- Department of Biochemistry, University of Otago, Dunedin, New Zealand.
ORCID-Profile: Khaled Elsaid, Tony R Merriman, Ru Liu-Bryan, Nicola Dalbeth, Ashika Chhana, Nancy Maltez, Robert Terkeltaub
Förderung
- BLRD VA
- NIAMS NIH HHS
- NIGMS NIH HHS
- NIA NIH HHS
- Health Research Council of New Zealand
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Institutes of Health
- Rheumatology Research Foundation
Zitieren
APA
Elsaid, K., Merriman, T. R., Rossitto, L. A., Liu-Bryan, R., Karsh, J., Phipps-Green, A., Jay, G. D., Elsayed, S., Qadri, M., Miner, M., Cadzow, M., Dambruoso, T. J., Schmidt, T. A., Dalbeth, N., Chhana, A., Höglund, J., Ghassemian, M., Campeau, A., Maltez, N., …, & Terkeltaub, R. (2023). Amplification of Inflammation by Lubricin Deficiency Implicated in Incident, Erosive Gout Independent of Hyperuricemia. Arthritis & Rheumatology, 75(5), 794-805. https://doi.org/10.1002/art.42413
Vancouver
Elsaid K, Merriman TR, Rossitto LA, Liu-Bryan R, Karsh J, Phipps-Green A, et al. Amplification of Inflammation by Lubricin Deficiency Implicated in Incident, Erosive Gout Independent of Hyperuricemia. Arthritis & Rheumatology. 2023;75(5):794-805. doi:10.1002/art.42413
BibTeX
@article{Elsaid2023,
author = {Elsaid, Khaled and Merriman, Tony R and Rossitto, Leigh-Ana and Liu-Bryan, Ru and Karsh, Jacob and Phipps-Green, Amanda and Jay, Gregory D and Elsayed, Sandy and Qadri, Marwa and Miner, Marin and Cadzow, Murray and Dambruoso, Talia J and Schmidt, Tannin A and Dalbeth, Nicola and Chhana, Ashika and Höglund, Jennifer and Ghassemian, Majid and Campeau, Anaamika and Maltez, Nancy and Karlsson, Niclas G and Gonzalez, David J and Terkeltaub, Robert},
title = {Amplification of Inflammation by Lubricin Deficiency Implicated in Incident, Erosive Gout Independent of Hyperuricemia},
journal = {Arthritis & Rheumatology},
year = {2023},
volume = {75},
number = {5},
pages = {794--805},
doi = {10.1002/art.42413}
}
EUVIMED